Erythrocyte-αPD-1 Conjugate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Erythrocyte-αPD-1 Conjugate, covering 2024-07-30 to 2024-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies [Phase 1]